Cited by 108Electrospun Nanofibers in Biomedical ApplicationsAdvanced Drug Delivery SystemsAdvancements in Transdermal Drug Delivery

Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery

Sharma, A., Gupta, A., Rath, G., Goyal, A., Mathur, R. B., Dhakate, S. R.·2013·Journal of Materials Chemistry B

Abstract

The intention of the present investigation was to develop an oral formulation for an anti-diabetic drug that not only could deliver it in the active form but also provide a sustained and controlled release profile. A biodegradable poly(vinyl alcohol) (PVA) and sodium alginate (NaAlg) electrospun composite nanofiber based transmucosal patch was developed and the anti-diabetic drug insulin was loaded in it by active loading. The drug entrapment in the composite nanofibers during the processing was confirmed by scanning electron microscopy, atomic force microscopy, X-ray diffraction and Fourier transform infrared spectroscopy. The in vivo studies were carried on male Wistar rats by the sublingual route. The mucoadhesive strength results confirmed that the drug loaded PVA-NaAlg nanofiber patch had the highest strength among the PVA, PVA-NaAlg and drug loaded PVA-NaAlg samples, due to its higher water holding capacity. The in vitro activity provided a sustained and controlled release pattern of the drug from the nanofiber patch. In vivo activity validated the fact that insulin was delivered in its active state and showed appreciable results when compared to the commercial formulation. The insulin release follows first order kinetics followed by an initial burst release necessary to produce the desired therapeutic activity. Furthermore an encapsulation efficacy of 99% of the experimental formulation provides sufficient indication that the composite nanofibers serve as an ideal carrier for the delivery of insulin via the sublingual route. Thus the present investigation gives impetus to work in the direction of delivering anti-diabetic drugs (proteins and peptides) via the oral route using electrospun composite nanofiber transmucosal patches.

Integrity signals

Registry

Crossref · 10.1039/c3tb20487a

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Drug-loaded nanofibers significantly lower blood glucose level in diabetic male Wistar rats and show better efficiency in controlling diabetes than commercial formulation.

    “The in vivo study confirmed the effectiveness of the drug-loaded nanofibers, as a significant lowering of the blood glucose level was observed in diabetic male Wistar rats. Furthermore, the patch showed better efficiency in controlling diabetes than did the commercial formulation.”
  • Insulin-loaded PVA-alginate composite nanofiber patch shows sustained and controlled release of insulin in vitro, with ~100% drug release within 12 h following first-order kinetics with initial burst.

    “The in vitro drug release study confirmed a sustained and controlled release pattern of the insulin from the nanofiber (Fig. 2a) and ~100% drug release from the patch occurred within 12 h. The release pattern follows first-order kinetics with an initial burst release of the drug.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sharma, A., Gupta, A., Rath, G., Goyal, A., Mathur, R. B., & Dhakate, S. R.
Affiliations
  • Indo Soviet Friendship College of Pharmacy (IN)
  • Council of Scientific and Industrial Research (IN)
Corresponding author
Dhakate, S. R.
Venue
Journal of Materials Chemistry B
Published
2013
Volume
1
Issue
27
Pages
3410
ISSN
  • 2050-750X (ISSN-L)
  • 2050-7518
OpenAlex
W1967686679
Cited by
108
References
40
Citations by year
2026: 5 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 14 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 8 · 2016: 7 · 2015: 4 · 2014: 8 · 2013: 1
FWCI
2.54
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Materials Chemistry B (publishedVersion)
  • PubMed (publishedVersion)
  • IR@NPL (CSIR-The National Physical Laboratory(NPL)) (acceptedVersion)
Funders
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Israel Science Foundation
Topics
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
electrospun nanofibers, sublingual drug delivery, insulin delivery, polyvinyl alcohol, sodium alginate, composite nanofibers, mucoadhesion, sustained drug release, encapsulation efficiency, oral protein delivery, antidiabetic drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review